References
Murray B, Carter R, Imrie C, et al.: Diclofenac reduces the indicence of acute pancreatitis after endoscopic retrograde cholangiopancreatography. Gastroenterology 124:1786–1791, 2003
Mallery JS, Baron TH, Dominitz JA, et al.: Complications of ERCP. Gastrointest Endosc 57:633–638, 2003
Loperfido S, Angelini G, Benedetti G, et al.: Major early complications from diagnostic and therapeutic ERCP: a prospective multicenter study. Gastrointest Endosc 48:1–10, 1998
Masci E, Toti G, Mariani A, et al.: Complications of diagnostic and therapeutic ERCP: a prospective multicenter study. Am J Gastroenterol 96:417–423, 2001
Freeman ML, DiSario JA, Nelson DB, et al.: Risk factors for post-ERCP pancreatitis: a prospective multicenter study. Gastrointest Endosc 54:425–434, 2001
Barthet M, Lesavre N, Desjeux A, et al.: Complications of endoscopic sphincterotomy: results from a single tertiary referral center. Endoscopy 34:991–997, 2002
Andriulli A, Leandro G, Niro G, et al.: Pharmacologic treatment can prevent pancreatic injury after ERCP: a meta-analysis. Gastrointest Endosc 51:1–7, 2000
Andriulli A, Clemente R, Teruzzi V, et al.: Gabexate or somatostatin administration before ERCP in patients at high-risk for post-ERCP pancreatitis: a multicenter placebo-controlled randomized clinical trial. Gastrointest Endosc 56:488–495, 2002
Binmoeller KF, Harris AG, Dumas R, et al.: Does the somatostatin analogue octreotide protect against ERCP induced pancreatitis? Gut 33:1129–1133, 1992
Arcidiacono R, Gambitta P, Rossi A, et al.: The use of a long-acting somatostatin analogue (octreotide) for prophylaxis of acute pancreatitis after endoscopic sphincterotomy. Endoscopy 26:715–718, 1994
Deviere J, Le Moine O, van Laethem JL, et al.: Interleukin-10 reduces the incidence of pancreatitis after therapeutic endoscopic retrograde cholangiopancreatography. Gastroenterology 120:498–505, 2001
Sudhindran S, Bromwich E, Edwards PR: Prospective randomized double-blind placebo-controlled trial of glyceryl trinitrate in endoscopic retrograde cholangiopancreatography-induced pancreatitis. Br J Surg 88:1178–1182, 2001
Moreto M, Zaballa M, Casado I, et al.: Transdermal glyceryl trinitrate for prevention of post-ERCP pancreatitis: a randomized double-blind trial. Gastrointest Endosc 57:1–7, 2003
Dumot JA, Conwell DL, Zuccaro G, et al.: A randomized double blind study of interleukin-10 for prevention of ERCP-induced pancreatitis. Am J Gastroenterol 96:2098–2102, 2001
Rabenstein T, Roggenbuck S, Framke B, et al.: Complications of endoscopic sphincterotomy: can heparin prevent acute pancreatitis after ERCP? Gastrointest Endosc 55:476–483, 2002
Tarnasky PR, Palesch YK, Cunningham JT, et al.: Pancreatic stenting prevents pancreatitis after biliary sphincterotomy in patients with sphincter of Oddi dysfunction. Gastroenterology 115:1518–1524, 1998
Fazel A, Quadri A, Catalano MF, et al.: Does a pancreatic duct stent prevent post-ERCP pancreatitis? A prospective randomized study. Gastrointest Endosc 57:291–294, 2003
Freeman ML: Prevention of post-ERCP pancreatitis: pharmacologic solution or patient selection and pancreatic stents? Gastroenterology 124:1977–1980, 2003 [editorial]
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Madanick, R.D., O’loughlin, C.J. & Barkin, J.S. Diclofenac Reduces the Incidence of AcutePancreatitis After Endoscopic Retrograde Cholangiopancreatography. Dig Dis Sci 50, 879–881 (2005). https://doi.org/10.1007/s10620-005-2658-x
Issue Date:
DOI: https://doi.org/10.1007/s10620-005-2658-x